David J. Lynn

12.0k total citations · 3 hit papers
95 papers, 5.1k citations indexed

About

David J. Lynn is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, David J. Lynn has authored 95 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 26 papers in Immunology and 16 papers in Cancer Research. Recurrent topics in David J. Lynn's work include Gut microbiota and health (10 papers), Cancer-related molecular mechanisms research (9 papers) and Bioinformatics and Genomic Networks (9 papers). David J. Lynn is often cited by papers focused on Gut microbiota and health (10 papers), Cancer-related molecular mechanisms research (9 papers) and Bioinformatics and Genomic Networks (9 papers). David J. Lynn collaborates with scholars based in Australia, Ireland and Canada. David J. Lynn's co-authors include Fiona S. L. Brinkman, Amir Foroushani, Robert E. W. Hancock, Cliona O’Farrelly, Geoffrey L. Winsor, Matthew R. Laird, Raymond Lo, Karin Breuer, Carol Chen and Andrew T. Lloyd and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

David J. Lynn

93 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation

2012 858 citations David J. Lynn et al. profile →
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

2022 187 citations Feargal J. Ryan, Miriam A. Lynn et al. profile →
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms

2021 178 citations David J. Lynn, Saoirse C. Benson et al. profile →

Peers

Countries citing papers authored by David J. Lynn

Since Specialization

Citations

This map shows the geographic impact of David J. Lynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Lynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Lynn more than expected).

Fields of papers citing papers by David J. Lynn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Lynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Lynn. The network helps show where David J. Lynn may publish in the future.

Co-authorship network of co-authors of David J. Lynn

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Lynn. A scholar is included among the top collaborators of David J. Lynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Lynn. David J. Lynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT 2025 ·Research and Practice in Thrombosis and Haemostasis ·Hannah Stevens, James D. McFadyen, Natalie A. Mellett, David J. Lynn, Thy Duong, Corey Giles, (unknown), (unknown), Georgina L. Eden, Miriam A. Lynn, Paul Monagle, Peter J. Meikle, Sanjeev Chunilal, Karlheinz Peter, Huyen Tran	1
2	DNA hydroxy methylases Tet1 and Tet2 regulate bone aging and bone marrow stromal cell metabolism through the IGF-1/mTOR signaling axis 2025 ·Stem Cells ·(unknown), Dimitrios Cakouros, Feargal J. Ryan, David J. Lynn, Sharon Paton, Agnieszka Arthur, Stan Gronthos	0
3	The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions 2024 ·FEBS Journal ·(unknown), Feargal J. Ryan, David J. Lynn	4
4	Diet at birth is critical for healthy growth, independent of effects on the gut microbiota 2024 ·Microbiome ·(unknown), Akila Rekima, Miriam A. Lynn, (unknown), (unknown), (unknown), (unknown), A.M. Middleton, Natalie E. Stevens, Florence Servant, Rémy Burcelin, David J. Lynn, Valérie Verhasselt	5
5	Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer 2023 ·British Journal of Cancer ·(unknown), Joanna L. Gillis, Chui Y. Mah, Swati Irani, Raj K. Shrestha, Natalie K. Ryan, Atsushi Enomoto, Zeyad D. Nassar, David J. Lynn, Luke A. Selth, Masashi Kato, Margaret M. Centenera, Lisa M. Butler	7
6	Protocol to assess the impact of early-life antibiotic exposure on murine longevity 2022 ·STAR Protocols ·Miriam A. Lynn, Feargal J. Ryan, (unknown), Saoirse C. Benson, David J. Lynn	4
7	Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice 2021 ·Vaccine ·Natalie E. Stevens, (unknown), (unknown), Feargal J. Ryan, Byron Brook, Nelly Amenyogbe, Helen Marshall, Miriam A. Lynn, Tobias R. Kollmann, Damon J. Tumes, David J. Lynn	8
8	OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice 2021 ·FASEB BioAdvances ·(unknown), Stephen J. Blake, David J. Lynn	2
9	The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota 2021 ·Cell Reports Medicine ·Stephen J. Blake, (unknown), Feargal J. Ryan, José A. Caparrós‐Martín, Georgina L. Eden, (unknown), (unknown), Saoirse C. Benson, Damon J. Tumes, (unknown), Natalie E. Stevens, John Finnie, Hiroki Kobayashi, Deborah L. White, Steve Wesselingh, Fergal O’Gara, Miriam A. Lynn, David J. Lynn	26
10	Zika Virus Infection of Human Iris Pigment Epithelial Cells 2021 ·Frontiers in Immunology ·Feargal J. Ryan, Jillian M. Carr, João M. Furtado, Yuefang Ma, Liam M. Ashander, (unknown), Genevieve F. Oliver, (unknown), (unknown), Michael Michael, Binoy Appukuttan, David J. Lynn, Justine R. Smith	12
11	Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition 2020 ·Molecular Cancer Research ·Zeyad D. Nassar, Chui Y. Mah, Margaret M. Centenera, Swati Irani, Martin C. Sadowski, Julia S. Scott, Elizabeth V. Nguyen, Shilpa R. Nagarajan, Max Moldovan, David J. Lynn, Roger J. Daly, Andrew J. Hoy, Lisa M. Butler	19
12	Changes in the Composition of the Gut Microbiota and the Blood Transcriptome in Preterm Infants at Less than 29 Weeks Gestation Diagnosed with Bronchopulmonary Dysplasia 2019 ·mSystems ·Feargal J. Ryan, Damian P. Drew, (unknown), Lex E. X. Leong, Max Moldovan, Miriam A. Lynn, (unknown), (unknown), Irmeli Penttila, Andrew J McPhee, Carmel T Collins, Maria Makrides, Robert A. Gibson, Geraint B. Rogers, David J. Lynn	30
13	Network Visualization and Analysis of Spatially Aware Gene Expression Data with InsituNet 2018 ·Cell Systems ·(unknown), Xiaoyan Qian, Mats Nilsson, David J. Lynn	11
14	The potential of the microbiota to influence vaccine responses 2017 ·Journal of Leukocyte Biology ·David J. Lynn, Bali Pulendran	69
15	A genome-wide association study for somatic cell score using the Illumina high-density bovine beadchip identifies several novel QTL potentially related to mastitis susceptibility 2013 ·Frontiers in Genetics ·(unknown), D.P. Berry, F. Kearney, Emma K. Finlay, Alan G. Fahey, Daniel G. Bradley, David J. Lynn	57
16	The bovine lactation genome: insights into the evolution of mammalian milk 2009 ·Genome biology ·Danielle G. Lemay, David J. Lynn, William Martin, Margaret Neville, Theresa Casey, Gonzalo Rincón, Evgenia V. Kriventseva, W Barris, Angie S. Hinrichs, Adrian Molenaar, Katherine S. Pollard, Nauman J. Maqbool, Kuljeet Singh, R. Murney, Evgeny M. Zdobnov, Ross L. Tellam, Juan F. Medrano, J. Bruce German, Monique Rijnkels	148
17	Detecting the effects of selection at the population level in six bovine immune genes 2008 ·BMC Genetics ·Abigail R Freeman, David J. Lynn, Caitríona Murray, Daniel G. Bradley	8
18	Transforming a Clinical Clerkship with Team Learning 2004 ·Teaching and Learning in Medicine ·Ruth Levine, Michael W. O’Boyle, Paul Haidet, David J. Lynn, (unknown), (unknown), Freddy A. Paniagua	165
19	Evidence of Positively Selected Sites in Mammalian α-Defensins 2004 ·Molecular Biology and Evolution ·David J. Lynn, Andrew T. Lloyd, Mario A. Fares, Cliona O’Farrelly	58
20	Bioinformatics: implications for medical research and clinical practice. 2003 ·PubMed ·David J. Lynn, (unknown), Cliona O’Farrelly	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact